全文获取类型
收费全文 | 1946篇 |
免费 | 144篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 146篇 |
妇产科学 | 15篇 |
基础医学 | 304篇 |
口腔科学 | 25篇 |
临床医学 | 108篇 |
内科学 | 379篇 |
皮肤病学 | 32篇 |
神经病学 | 179篇 |
特种医学 | 73篇 |
外科学 | 147篇 |
综合类 | 186篇 |
预防医学 | 113篇 |
眼科学 | 32篇 |
药学 | 116篇 |
中国医学 | 7篇 |
肿瘤学 | 205篇 |
出版年
2022年 | 16篇 |
2021年 | 32篇 |
2020年 | 20篇 |
2019年 | 24篇 |
2018年 | 40篇 |
2017年 | 28篇 |
2016年 | 22篇 |
2015年 | 42篇 |
2014年 | 57篇 |
2013年 | 76篇 |
2012年 | 97篇 |
2011年 | 105篇 |
2010年 | 63篇 |
2009年 | 78篇 |
2008年 | 98篇 |
2007年 | 115篇 |
2006年 | 94篇 |
2005年 | 108篇 |
2004年 | 89篇 |
2003年 | 73篇 |
2002年 | 60篇 |
2001年 | 68篇 |
2000年 | 63篇 |
1999年 | 58篇 |
1998年 | 56篇 |
1997年 | 33篇 |
1996年 | 36篇 |
1995年 | 17篇 |
1994年 | 21篇 |
1993年 | 11篇 |
1992年 | 27篇 |
1991年 | 31篇 |
1990年 | 28篇 |
1989年 | 32篇 |
1988年 | 34篇 |
1987年 | 20篇 |
1986年 | 24篇 |
1985年 | 29篇 |
1984年 | 19篇 |
1983年 | 16篇 |
1981年 | 12篇 |
1980年 | 10篇 |
1979年 | 14篇 |
1978年 | 15篇 |
1977年 | 12篇 |
1976年 | 10篇 |
1975年 | 8篇 |
1974年 | 11篇 |
1972年 | 7篇 |
1970年 | 7篇 |
排序方式: 共有2098条查询结果,搜索用时 15 毫秒
31.
Shambhu Baitha R. M. Raizada A. K. Kennedy Singh M. P. Puttewar V. N. Chaturvedi 《Indian journal of otolaryngology and head and neck surgery》2004,56(3):186-190
A study comprising 110 patients with hoarseness of voice was carried out between Jan 1998 and September 1999 to find out the predisposing factors and aetiology oj the condition Septic foci in nose and throat and vocal abuse were the common predisposing factors observed in 41 8% and 40 9% cases respectively Chronic non specific laryngitis was the commonest aetiology of hoarseness of voice seen in 43 6% of cases 相似文献
32.
Interest in the knowledge of salivary gland tumours is highlighted. A sample of 315 cases, collected over a period of 25 years in a busy pathology centre, is analysed both on total and individual aspects of tumours. The findings are compared to earlier works on the subject and also with contemporary literature.KEY WORDS: Pathological study, Salivary tumours 相似文献
33.
34.
Chaturvedi K Jiang X Christoffers KH Chinen N Bandari P Raveglia LF Ronzoni S Dondio G Howells RD 《Brain research. Molecular brain research》2000,80(2):166-176
Several non-peptidic opioids have been synthesized recently as part of a program to develop selective delta receptor agonists. In this study, the affinities of a set of compounds for cloned delta and mu opioid receptors expressed in HEK 293 cell lines were determined by competition analysis of [3H]bremazocine binding to membrane preparations. All compounds studied exhibited high affinity and selectivity, with apparent dissociation constants in the range of 0.6-1.7 nM for the delta opioid receptor and 240-1165 nM for the mu opioid receptor. We next sought to determine which domain of the delta receptor was critical for mediating the highly selective binding by analysis of ligand affinities for mu/delta receptor chimeras. Receptor binding profiles suggested that a critical site of receptor/ligand interaction was located between transmembrane domain 5 (TM5) and TM7 of the delta receptor. Substitution of tryptophan 284, located at the extracellular surface of TM6, with lysine, which is found at the equivalent position in the mu opioid receptor, led to a spectrum of effects on affinities, depending on the ligand tested. Affinities of SB 219825 and SB 222941 were particularly sensitive to the substitution, displaying a 50-fold and 70-fold decrease in affinity, respectively. Activities of the delta receptor-selective agonists were tested in two functional assays. Brief exposure of HEK 293 cells expressing delta opioid receptors with selective ligands induced phosphorylation of MAP kinase, although the non-peptidic ligands were less efficacious than the enkephalin derivative DADL (Tyr-D-Ala-Gly-Phe-D-Leu). Similarly, chronic exposure of HEK 293 cells expressing delta opioid receptors with selective, non-peptidic ligands, with the exception of SB 206848, caused receptor down-regulation, however, the SB compounds were less efficacious than DADL. 相似文献
35.
The importance of the amino-terminal domain of the mu opioid receptor (MOR) as a component of the high affinity ligand-binding pocket was evaluated. A deletion mutant lacking 64 amino acids from the amino-terminus of MOR (DeltaN64) was constructed and expressed in HEK 293 cells. The affinities of bremazocine and cyclazocine were similar for the truncated and full-length MORs. Affinities of the mu receptor antagonist, naloxone, and the mu receptor agonist, morphine, were decreased 3.5-fold and 6-fold, respectively, for the truncated receptor relative to the wild-type MOR. Similarly, the affinities of the opioid peptide agonists, DAMGO (Tyr-D-Ala-Gly-MePhe-Gly-ol), beta-endorphin, and DADL (Tyr-D-Ala-Gly-Phe-D-Leu), for the DeltaN64 receptor were decreased from 3- to 8-fold as a result of the deletion. In contrast, the affinities of the alkaloid agonists, methadone and fentanyl, and the peptide agonists, endomorphin 1 and endomorphin 2, for the truncated receptor relative to MOR were reduced dramatically by 20- to 60-fold. MOR is glycosylated when expressed in HEK 293 cells; however, analysis of N-glycosidase F-treated membranes indicated that N-glycan chains within the amino-terminal domain of MOR do not contribute significantly to ligand affinities. These results indicate that amino acid residues within the amino-terminal domain of MOR play a crucial role in the composition of the binding pocket for a select group of agonists. 相似文献
36.
T. Julius S.E.G. Kemp P.J. Kneeshaw A. Chaturvedi P.J. Drew L.W. Turnbull 《European journal of surgical oncology》2005,31(10):1129-1134
AIMS: The objectives of this study were to compare the efficacy of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in assessing the response of primary breast carcinoma to neoadjuvant chemotherapy compared to conventional imaging modalities, and to see how surgical outcome was influenced as a result of these findings. METHODS: Thirty-four patients with locally advanced primary breast cancer underwent conventional imaging and DCE-MRI following six cycles of neoadjuvant chemotherapy prior to surgery. Changes in surgical management based on the post-chemotherapy DCE-MRI findings were recorded. RESULTS: Prior to neoadjuvant chemotherapy, 22 of the 34 patients were assessed as requiring mastectomy and the remaining 12 were considered inoperable. Following chemotherapy two patients were still considered inoperable. In 11 of the 34 patients, the final decision to proceed to either mastectomy or non-surgical management was based primarily on pre-treatment disease status or patient choice. DCE-MRI findings, therefore, contributed to the operative decision in 21 of 34 patients. Two of these 21 patients were spared surgery as DCE-MRI demonstrated complete response to chemotherapy and one declined surgery. The remaining 18 were able to undergo wide local excision, with only two patients subsequently requiring mastectomy for involved margins. CONCLUSIONS: DCE-MRI is able to accurately predict those patients suitable for breast conserving surgery following neoadjuvant chemotherapy and should be the imaging modality of choice in assessing the response of patients with primary breast carcinoma to neoadjuvant chemotherapy. 相似文献
37.
Multilaboratory Evaluation of In Vitro Antifungal Susceptibility Testing of Dermatophytes for ME1111
M. Ghannoum V. Chaturvedi D. Diekema L. Ostrosky-Zeichner R. Rennie T. Walsh N. Wengenack A. Fothergill N. Wiederhold 《Journal of clinical microbiology》2016,54(3):662-665
ME1111 is a novel small molecule antifungal agent under development for the topical treatment of onychomycosis. Standardization of the susceptibility testing method for this candidate antifungal is needed. Toward this end, 8 independent laboratories determined the interlaboratory reproducibility of ME1111 susceptibility testing. In addition, we subsequently identified 2 strains as quality control (QC) isolates for the method. In the reproducibility study, 5 blinded clinical strains each of Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum were tested, while the QC study tested 6 blinded T. rubrum or T. mentagrophytes ATCC strains. Testing was performed in frozen microtiter panels according to the Clinical and Laboratory Standards Institute (CLSI) M38-A2 methodology. In the reproducibility study, 9 of 15 clinical strains showed interlaboratory agreement of >90% at the 80% inhibition endpoint, with a range of agreement of 76.2% to 100%. In the QC study, 4 of the 6 ATCC strains showed interlaboratory agreement of >90%. ME1111 demonstrated excellent interlaboratory agreement when tested against dermatophytes. Based on this data, the CLSI Subcommittee on Antifungal Susceptibility Tests approved the susceptibility testing of ME1111 against dermatophytes according to M38-A2 methodology, which stipulates RPMI 1640 as the test medium, an inoculum size of 1 to 3 × 103 CFU/ml, and an incubation time and temperature of 96 h at 35°C. The MIC endpoint should be 80% inhibition compared with the growth control. T. rubrum ATCC MYA-4438 and T. mentagrophytes ATCC 28185 were selected as QC isolates, with an acceptable range of 0.12 to 1 μg/ml for the two strains. 相似文献
38.
Gaurav Khanna Pankaj Pathak Vaishali Suri Mehar Chand Sharma Sujata Chaturvedi Arvind Ahuja M. Bhardwaj Ajay Garg Chitra Sarkar Rajeev Sharma 《Pathology, research and practice》2018,214(5):679-685
Epithelioid glioblastoma (e-gbm) is a recently described variant of glioblastoma (GBM) which is associated with short survival and now added as a provisional entity to WHO 2016 classification of CNStumors. About half of these tumors show characteristic BRAF-V600E mutation. However, unlike conventional GBMs, e-gbm lack specific diagnostic and prognostic markers. Hence, we aimed to molecularly characterize these tumors. An extensive review of literature was performed.In a multi-institutional effort, all the cases of glioblastoma of year 2017 were reviewed. Cases with predominant epithelioid morphology were analysed. Seven cases of e-gbm (adults:4 and pediatric: 3) were identified. Duration of symptoms varied from 2 weeks to one month. Radiologically, all cases were supratentorial, contrast enhancing with solid and cystic appearance. Majority of the cases were immunopositive for GFAP (71%), EMA (71%), S100 (71%) and vimentin (85%). All the cases showed ATRX, INI-1 and H3K27me3 expression. BRAFV600Emutation was seen in 28% of cases. TERT mutation was seen in 40% cases, while one case showed EGFR amplification. H3F3A mutations and PTEN deletions were seen in none. Although e-gbms are rare, epithelioid morphology of a CNS tumor in a young adult or children with areas of necrosis needs thorough histomorphological and genetic workup. 相似文献
39.
40.